KR20190020950A - Low irritating cosmetic composition for skin whitening comprising albutin - Google Patents
Low irritating cosmetic composition for skin whitening comprising albutin Download PDFInfo
- Publication number
- KR20190020950A KR20190020950A KR1020170105916A KR20170105916A KR20190020950A KR 20190020950 A KR20190020950 A KR 20190020950A KR 1020170105916 A KR1020170105916 A KR 1020170105916A KR 20170105916 A KR20170105916 A KR 20170105916A KR 20190020950 A KR20190020950 A KR 20190020950A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- extract
- parts
- cosmetic composition
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 239000002537 cosmetic Substances 0.000 title claims abstract description 62
- 230000002087 whitening effect Effects 0.000 title claims abstract description 41
- 239000000284 extract Substances 0.000 claims abstract description 84
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims abstract description 64
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 39
- 150000001413 amino acids Chemical class 0.000 claims abstract description 37
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 37
- 239000011570 nicotinamide Substances 0.000 claims abstract description 37
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 37
- 240000003394 Malpighia glabra Species 0.000 claims abstract description 35
- 235000014837 Malpighia glabra Nutrition 0.000 claims abstract description 35
- 229960000271 arbutin Drugs 0.000 claims abstract description 32
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims abstract description 32
- 235000004433 Simmondsia californica Nutrition 0.000 claims abstract description 28
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 26
- 239000001140 aloe barbadensis leaf extract Substances 0.000 claims abstract description 25
- 244000269722 Thea sinensis Species 0.000 claims abstract description 16
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 10
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 244000044822 Simmondsia californica Species 0.000 claims abstract description 5
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 42
- 244000308180 Brassica oleracea var. italica Species 0.000 claims description 42
- 235000001014 amino acid Nutrition 0.000 claims description 37
- 229940024606 amino acid Drugs 0.000 claims description 37
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 36
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims description 27
- 241000221095 Simmondsia Species 0.000 claims description 23
- 229940069638 aloe vera leaf extract Drugs 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 21
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 10
- 229940098324 green tea leaf extract Drugs 0.000 claims description 10
- 244000144927 Aloe barbadensis Species 0.000 claims description 9
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 9
- 235000011399 aloe vera Nutrition 0.000 claims description 9
- 239000006071 cream Substances 0.000 claims description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 6
- 235000005772 leucine Nutrition 0.000 claims description 6
- 235000002374 tyrosine Nutrition 0.000 claims description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 6
- 239000004475 Arginine Substances 0.000 claims description 5
- 239000004471 Glycine Substances 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 5
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 5
- 239000004472 Lysine Substances 0.000 claims description 5
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 5
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 235000009697 arginine Nutrition 0.000 claims description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 5
- 235000003704 aspartic acid Nutrition 0.000 claims description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 5
- 235000018417 cysteine Nutrition 0.000 claims description 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 5
- 235000014304 histidine Nutrition 0.000 claims description 5
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 235000018977 lysine Nutrition 0.000 claims description 5
- 235000008729 phenylalanine Nutrition 0.000 claims description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 5
- 235000013930 proline Nutrition 0.000 claims description 5
- 235000014393 valine Nutrition 0.000 claims description 5
- 239000004474 valine Substances 0.000 claims description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 4
- 239000004473 Threonine Substances 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 235000014705 isoleucine Nutrition 0.000 claims description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 4
- 229960000310 isoleucine Drugs 0.000 claims description 4
- 235000006109 methionine Nutrition 0.000 claims description 4
- 229930182817 methionine Natural products 0.000 claims description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 4
- 235000004400 serine Nutrition 0.000 claims description 4
- 235000008521 threonine Nutrition 0.000 claims description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 239000008269 hand cream Substances 0.000 claims 1
- 206010040880 Skin irritation Diseases 0.000 abstract description 22
- 231100000475 skin irritation Toxicity 0.000 abstract description 22
- 230000036556 skin irritation Effects 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 19
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 235000011303 Brassica alboglabra Nutrition 0.000 abstract 1
- 240000007124 Brassica oleracea Species 0.000 abstract 1
- 235000011302 Brassica oleracea Nutrition 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 51
- 230000000052 comparative effect Effects 0.000 description 21
- 206010015150 Erythema Diseases 0.000 description 14
- 231100000321 erythema Toxicity 0.000 description 13
- 235000020688 green tea extract Nutrition 0.000 description 13
- 229940094952 green tea extract Drugs 0.000 description 13
- 208000012641 Pigmentation disease Diseases 0.000 description 9
- 230000019612 pigmentation Effects 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 229940075529 glyceryl stearate Drugs 0.000 description 5
- 235000009569 green tea Nutrition 0.000 description 5
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 4
- 229940081733 cetearyl alcohol Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- SDPBXXCJVDQPIQ-UHFFFAOYSA-N hexadecyl hexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC SDPBXXCJVDQPIQ-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- HKIKAXXIWJHWLY-ZIIYPAMZSA-N Aloesin Chemical compound C=12OC(CC(=O)C)=CC(=O)C2=C(C)C=C(O)C=1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HKIKAXXIWJHWLY-ZIIYPAMZSA-N 0.000 description 1
- HKIKAXXIWJHWLY-QEVGBQTESA-N Aloesin Natural products O=C(CC=1Oc2c([C@H]3[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)c(O)cc(C)c2C(=O)C=1)C HKIKAXXIWJHWLY-QEVGBQTESA-N 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 239000001744 Sodium fumarate Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 1
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003527 anti-angiogenesis Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- -1 cetylhexylhexanoate Chemical compound 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- MSJMDZAOKORVFC-SEPHDYHBSA-L disodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- WPHGSKGZRAQSGP-UHFFFAOYSA-N methylenecyclohexane Natural products C1CCCC2CC21 WPHGSKGZRAQSGP-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 239000003009 skin protective agent Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940005573 sodium fumarate Drugs 0.000 description 1
- 235000019294 sodium fumarate Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940083608 sodium hydroxide Drugs 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 229940114926 stearate Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
- A61K2800/72—Hypo-allergenic
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical & Material Sciences (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 알부틴, 나이아신아마이드 및 피부 진정 성분을 유효성분으로 포함하는 저자극성 피부 미백용 화장료 조성물에 관한 것이다.The present invention relates to a hypoallergenic skin whitening cosmetic composition comprising arbutin, niacinamide and a skin soothing component as an active ingredient.
사람의 피부색은 피부 내부의 멜라닌(melanin) 농도와 분포에 따라 결정되는데, 유전적인 요인 외에도, 태양 자외선이나 피로, 스트레스 등의 환경적 또는 생리적 조건에 의해서도 영향을 받는다. 멜라닌은 피부 표피층에 있는 멜라노사이트에서 합성되는데, 멜라노사이트 내 소기관인 멜라노좀(melanosome)에서 아미노산의 일종인 티로신(tyrosine)에 티로시나제(tyrosinase)라는 효소가 작용하여 도파(DOPA), 도파퀴논(dopaquinone)으로 바뀐 후 비효소적인 산화반응을 거쳐 만들어진다. 이와 같은 멜라닌의 합성이 피부 내에서 과도하게 일어나면, 피부 톤을 어둡게 하고, 기미, 주근깨 등을 발생시킨다. 따라서, 피부 내의 티로시나제 활성을 저해하여 멜라닌 색소의 합성을 저해시키면, 피부 톤을 밝게 하여 피부 미백을 실현할 수 있을 뿐만 아니라 자외선, 호르몬 및 유전적인 원인에 기인하여 발생하는 기미, 주근깨 등의 피부 과색소 침착증을 개선시킬 수 있다.The skin color of a person is determined by the concentration and distribution of melanin in the skin. In addition to hereditary factors, it is also affected by environmental or physiological conditions such as sunlight, fatigue, and stress. Melanin is synthesized in melanocytes in the epidermis of the skin. In the melanosome of melanocytes, an enzyme called tyrosinase acts on tyrosine, a type of amino acid, resulting in dopa (DOPA), dopaquinone ), And then it is made through a non-enzymatic oxidation reaction. When such a synthesis of melanin occurs excessively in the skin, it darkens skin tone, and causes spots and freckles. Thus, inhibiting the activity of tyrosinase in the skin to inhibit the synthesis of melanin pigment not only makes it possible to whiten the skin tone to brighten the skin tone, but also to reduce skin irritation caused by ultraviolet rays, hormones and hereditary causes, It can improve constipation.
이러한 티로시나아제의 활동을 억제할 수 있는 물질로서 히드로퀴논, 아스콜빈산, 코직산, 글루타치온, 알부틴, 상백피 추출물을 비롯한 다양한 추출물들이 이용되어 왔으나, 피부의 안전성과 화장료 제형의 안정성에 문제점을 가지고 있으며, 알부틴의 경우, 피부 자극을 유발시키는 부작용이 나타나는 문제점이 있다.A variety of extracts including hydroquinone, ascorbic acid, kojic acid, glutathione, arbutin, and bark extract have been used as substances capable of inhibiting the activity of tyrosinase. However, they have problems in safety of skin and stability of cosmetic formulation, In the case of arbutin, side effects that cause skin irritation occur.
이러한 배경하에 본 발명자들은 미백효과를 가지면서 피부 자극 등 인체 부작용이 적은 물질을 개발하기 위해 계속 연구를 진행한 결과, 알부틴, 나이아신아마이드, 알로에베라잎 추출물, 아세로라 추출물, 녹차 추출물 및 브로콜리 추출물을 함유하는 화장료 조성물의 우수한 미백 효과를 나타내면서도 피부 자극이 완화되는 것을 확인하여, 본 발명을 완성하였다.Under these circumstances, the inventors of the present invention have continued to develop a substance having a whitening effect and a less adverse side effect such as skin irritation. As a result, it has been found that it contains arbutin, niacinamide, aloe vera leaf extract, acerola extract, green tea extract and broccoli extract And the skin irritation is alleviated while exhibiting an excellent whitening effect of the cosmetic composition. Thus, the present invention has been completed.
따라서, 본 발명의 목적은 피부 자극 완화 및 미백 효과를 갖는 알부틴(albutin), 나이아신아마이드(niacinamide), 알로에베라잎(Aloe barbadensis leaf) 추출물, 아세로라(Malpighia emarginata fruit) 추출물, 녹차(Camellia sinensis leaf) 추출물 및 브로콜리(Brassica oleracea var. Italica) 추출물을 유효성분으로 포함하는 피부 미백용 화장료 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide an extract of albutin, niacinamide, Aloe barbadensis leaf, Malpighia emarginata fruit, Camellia sinensis leaf, Extract and broccoli (Brassica oleracea var. Italica) extract as an active ingredient.
상기와 같은 본 발명의 목적을 달성하기 위하여, 본 발명은 알부틴(albutin), 나이아신아마이드(niacinamide), 알로에베라잎(Aloe barbadensis leaf) 추출물, 아세로라(Malpighia emarginata fruit) 추출물, 녹차(Camellia sinensis leaf) 추출물 및 브로콜리(Brassica oleracea var. Italica) 추출물을 유효성분으로 포함하는 피부 미백용 화장료 조성물을 제공한다.In order to accomplish the object of the present invention, the present invention provides a method for producing an extract of albutin, niacinamide, Aloe barbadensis leaf, Malpighia emarginata fruit, Camellia sinensis leaf, Extract and broccoli (Brassica oleracea var. Italica) extract as an active ingredient.
또한, 본 발명은 상기 피부 미백용 화장료 조성물에 호호바씨 오일(Simmondsia chinensis seed oil) 및 아미노산 복합체(amino acid complex)를 추가로 더 포함하는 피부 미백용 화장료 조성물을 제공한다.Also, the present invention provides a cosmetic composition for skin whitening comprising the cosmetic composition for skin whitening, further comprising a cosmetic composition comprising a cosmetic composition comprising a cosmetic composition comprising:
본 발명의 알부틴, 나이아신아마이드, 알로에베라잎 추출물, 아세로라 추출물, 녹차 추출물, 브로콜리 추출물, 호호바씨 오일 및 아미노산 복합체를 유효성분으로 포함하는 피부 미백용 화장료 조성물은 알부틴 및 나이아신아마이드 사용시 유발될 수 있는 피부 자극을 완화시키는 피부 진정 효과를 가지며, 우수한 피부 미백 효과가 있어 미백용 화장료 조성물로 유용하게 이용할 수 있다.The cosmetic composition for skin whitening comprising arbutin, niacinamide, aloe vera leaf extract, acerola extract, green tea extract, broccoli extract, jojoba seed oil and amino acid complex of the present invention as an active ingredient can be used for skin Has a skin soothing effect to alleviate irritation, has an excellent skin whitening effect, and can be effectively used as a whitening cosmetic composition.
본 발명자들은 알부틴(albutin), 나이아신아마이드(niacinamide), 알로에베라잎(Aloe barbadensis leaf) 추출물, 아세로라(Malpighia emarginata fruit) 추출물, 녹차(Camellia sinensis leaf) 추출물, 브로콜리(Brassica oleracea var. Italica) 추출물, 호호바씨 오일(Simmondsia chinensis seed oil) 및 아미노산 복합체(amino acid complex)를 함유하는 화장료 조성물이 미백 효과뿐만 아니라 피부 진정 효과를 나타낸다는 사실을 발견함으로써 본 발명을 완성하였다.The present inventors have found that the extracts of albutin, niacinamide, Aloe barbadensis leaf, Malpighia emarginata fruit, Camellia sinensis leaf, Broccoli (Brassica oleracea var. Italica) The present invention has been accomplished by discovering that a cosmetic composition containing Simmondsia chinensis seed oil and an amino acid complex exhibits whitening effect as well as skin soothing effect.
특히, 본 발명에서는 알부틴, 나이아신아마이드, 알로에베라잎 추출물, 아세로라 추출물, 녹차 추출물 및 브로콜리 추출물을 혼합한 화장료 조성물을 사용할 경우 이들 성분의 일부를 포함하는 조성물보다 미백 효과가 현저하게 향상된다는 사실을 실험적으로 입증하였다(실험예 1 참조).Particularly, in the present invention, when a cosmetic composition prepared by mixing arbutin, niacinamide, aloe vera leaf extract, acerola extract, green tea extract and broccoli extract is used, the whitening effect is remarkably improved as compared with a composition containing a part of these components. (See Experimental Example 1).
따라서, 본 발명은 알부틴(albutin), 나이아신아마이드(niacinamide), 알로에베라잎(Aloe barbadensis leaf) 추출물, 아세로라(Malpighia emarginata fruit) 추출물, 녹차(Camellia sinensis leaf) 추출물 및 브로콜리(Brassica oleracea var. Italica) 추출물을 유효성분으로 포함하는 피부 미백용 화장료 조성물을 제공함에 특징이 있다.Accordingly, the present invention relates to a composition comprising albutin, niacinamide, Aloe barbadensis leaf extract, Malpighia emarginata fruit extract, Camellia sinensis leaf extract and Broccoli (Brassica oleracea var. Italica) The present invention provides a cosmetic composition for skin whitening comprising an extract as an active ingredient.
본 발명의 상기 알부틴(albutin)은 월귤나무에 다량 함유되어 있는 물질로 미백에 효과가 좋은 성분이며, 멜라닌 생성 억제 성분인 하이드로퀴논과 유사한 화학 구조로써, 산화방지제, 피부 컨디셔닝제, 미백개선 효능이 있음은 물론, 제형의 안정성 때문에 세계적으로 널리 사용되는 물질이다.The albutin of the present invention is a substance which is contained in a large amount in a mushroom and is effective for whitening. It is a chemical structure similar to hydroquinone, which is a melanin production inhibiting ingredient, and has antioxidant, skin conditioning agent, whitening improving effect And is widely used worldwide due to the stability of the formulation.
본 발명의 상기 나이아신아마이드(niacinamide)는 비타민B군인 나이아신류의 일종으로, 나이아신아마이드는 니코틴아마이드라고도 알려진 수용성 비타민 B3이다. 세라마이드와 함께 라멜라 구조형성에 필요한 콜레스테롤과 지방산의 합성을 동시에 촉진하여 표피의 수분 상실을 감소시키고 지질량을 개선하는 효과가 있으며, 화장품 분야에서 미백 효과를 얻기 위하여 사용하고 있다.The niacinamide of the present invention is a kind of niacin, a vitamin B group, and niacinamide is a water-soluble vitamin B3, also known as nicotinamide. It has the effect of simultaneously promoting the synthesis of cholesterol and fatty acid necessary for formation of lamellar structure together with ceramides, thereby reducing moisture loss of the epidermis and improving the fat mass, and is used for obtaining a whitening effect in the field of cosmetics.
본 발명의 상기 알로에베라잎(Aloe barbadensis leaf (Aloe Vera))은 지중해 지방과 아프리카가 원산지이며, 비타민 A, C, D, E, B12, 지방산, 아미노산, 셀레늄, 칼슘 및 알로인(aloin), 알로에신(aloesin) 등 약 300여 가지의 다양한 성분을 함유하고 있다. 잎에 함유된 젤 형태의 수액은 화상과 관절염을 치료하는 효과가 있는 것으로 알려져 있고, 화장품 및 약제의 원료, 식용 등 다양한 용도로 사용되며 살균 및 의한 독소 중화, 피로 회복 및 피부 중성화, 해열, 변비 및 궤양에도 효과가 있다고 밝혀져 있다.The aloe barbadensis leaf (Aloe Vera) of the present invention is originated from the Mediterranean region and Africa and contains vitamin A, C, D, E, B12, fatty acid, amino acid, selenium, calcium and aloin, And aloesin. It contains about 300 various components. The gel-like liquid contained in the leaves is known to have an effect of treating burns and arthritis. It is used for various purposes such as raw materials for cosmetics and pharmaceuticals, and for food. It neutralizes toxins caused by sterilization, fatigue and skin neutralization, And ulcers.
본 발명의 상기 아세로라(Malpighia emarginata fruit (Acerola))는 브라질에서 자생하는 말피기아(Malphigia)족의 관목에서 생산되는 열매이며, 비타민, 미네랄 등을 함유하고 있으며, 특히 비타민 C가 풍부하다. 또한, 항산화 물질인 안토시아닌과 폴리페놀이 풍부하여 노화억제 효과가 우수하고, 피부 청정 효과와 보습 효과 및 수렴작용이 있는 것으로 알려져 있다.The above-mentioned acerola (Malpighia emarginata fruit (Acerola)) is a fruit produced in a shrub of a Malphigia family native to Brazil, and contains vitamins, minerals and the like, and is particularly rich in vitamin C. In addition, it is known that antioxidants such as anthocyanin and polyphenol are abundant, so that they have excellent aging suppressing effect, and have a skin cleansing effect, a moisturizing effect and a converging action.
본 발명의 상기 녹차(Camellia sinensis leaf)는 동백나무과에 속하는 차나무(Camellia sinensis)의 싹이나 잎을 이용하여 차엽 속에 존재하는 산화효소를 화열(火熱)이나 증기로 실활(失活)시켜 제조한 것으로서, 기원전부터 기호차로서 음용되어져 왔다. 녹차에 함유된 여러 성분들의 약리적인 메커니즘이 점차 밝혀짐에 따라 그 가치가 일반인들에게도 인식되고 있는데, 대표적으로 항산화, 항염증, 항돌연변이, 심장질환예방, 항혈관형성, 세포사멸, 비만예방, 콜레스테롤강하, 항동맥경화증, 항당뇨, 항균, 항바이러스, 노화방지 등의 약리작용이 알려진 바 있다. The green tea (Camellia sinensis leaf) of the present invention is prepared by inactivating an oxidizing enzyme present in the leaves of a camellia sinensis using fire or steam using shoots or leaves of Camellia sinensis belonging to Camellia sinensis , Has been consumed as a symbol of tea since BC. As the pharmacological mechanism of the various ingredients in green tea is becoming more and more known, its value is recognized by the general public as well. Antioxidants, antiinflammation, antimutagenesis, prevention of heart disease, antiangiogenesis, apoptosis, Cholesterol lowering, atherosclerosis, anti-diabetic, antimicrobial, antiviral, and anti-aging.
본 발명의 상기 브로콜리(Brassica oleracea var. Italica (Broccoli))는 십자화과에 속하는 식물로서, 항산화 작용을 갖는 베타-카로틴, 루틴, 아스코르빈산, 셀레늄, 케르세틴, 글루타티온 등이 다량 함유되어 있고, 칼슘, 비타민C, 엽산 등의 영양 성분을 함유한다. 브로콜리는 피부 속 콜라겐 합성을 증가시키고 피부 노화를 방지하며, 유해 물질로부터 피부 저항력을 향상시키는데 관여하며, 피부에 긴장감을 부여하고 모공 수렴 작용에 도움을 주는 효과가 있다.The broccoli (Brassica oleracea var. Italica (Broccoli)) of the present invention is a plant belonging to the group of crucifers and contains a large amount of beta-carotene, rutin, ascorbic acid, selenium, quercetin, glutathione, Vitamin C, and folic acid. Broccoli is effective in increasing collagen synthesis in the skin, preventing aging of the skin, enhancing skin resistance from harmful substances, imparting tension to the skin, and helping the pore convergence.
본 발명에 따른 상기 알로에베라잎 추출물, 아세로라 추출물, 녹차 추출물 및 브로콜리 추출물은 당업계에 공지된 추출 및 분리하는 방법을 사용하여 추출물을 분리 및 수득한 것을 사용할 수 있으며, 본 발명에서 정의된 추출물은 적절한 용매를 이용하여 상기 알로에베라잎, 아세로라, 녹차 또는 브로콜리로부터 추출할 수 있다. 이때 추출물을 수득하기 위해 사용할 수 있는 적절한 용매로는 당업계에서 허용되는 용매라면 어느 것을 사용해도 무방하며, 물 또는 유기용매를 사용할 수 있다. 예를 들어, 정제수, 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올(isopropanol), 부탄올(butanol) 등을 포함하는 탄소수 1 내지 4의 알코올, 아세톤(acetone), 에테르(ether), 벤젠(benzene), 클로로포름(chloroform), 에틸아세테이트(ethyl acetate), 메틸렌클로라이드(methylene chloride), 헥산(hexane) 및 시클로헥산(cyclohexane) 등의 각종 용매를 단독으로 혹은 혼합하여 사용할 수 있으나, 이에 제한되지는 않는다. The aloe vera leaf extract, acerola extract, green tea extract and broccoli extract according to the present invention can be obtained by extracting and extracting the extract using methods known in the art for extracting and isolating the extract, Can be extracted from the aloe vera leaves, acerola, green tea or broccoli using an appropriate solvent. Any suitable solvent that can be used to obtain the extract may be any of those accepted in the art, and water or an organic solvent may be used. Examples of the solvent include alcohols having 1 to 4 carbon atoms, acetone, ether, and the like, including purified water, methanol, ethanol, propanol, isopropanol, butanol, Various solvents such as benzene, chloroform, ethyl acetate, methylene chloride, hexane and cyclohexane may be used alone or in combination. But is not limited to.
추출 방법으로는 열수추출법, 냉침추출법, 환류냉각추출법, 용매추출법, 수증기증류법, 초음파추출법, 용출법, 압착법 등의 방법 중 어느 하나를 선택하여 사용할 수 있다. 또한, 목적하는 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다. 본 발명의 상기 추출물의 제조방법에는 제한이 없으며, 공지되어 있는 어떠한 방법도 이용될 수 있다.As the extraction method, any one of the methods such as hot water extraction method, cold extraction method, reflux cooling extraction method, solvent extraction method, steam distillation method, ultrasonic extraction method, elution method and compression method can be selected and used. In addition, the desired extract may be further subjected to a conventional fractionation process or may be purified using a conventional purification method. There is no limitation on the method for producing the extract of the present invention, and any known method can be used.
예를 들면, 본 발명의 조성물에 포함되는 알로에베라잎, 아세로라, 녹차 및 브로콜리 추출물은 상기한 용매 추출법으로 추출된 1차 추출물을, 원심분리, 여과, 농축후 동결 건조하여 냉장실에 보관하면서 그대로 사용할 수도 있고, 상기 1차 추출물을 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다. 또한, 상기 1차 추출물을 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 박층 크로마토그래피(thin layer chromatography), 고성능 액체 크로마토그래피(high performance liquid chromatography)등과 같은 다양한 크로마토그래피를 이용하여 추가로 정제된 분획을 얻을 수도 있다. For example, the aloe vera leaf, acerola, green tea and broccoli extracts contained in the composition of the present invention are subjected to centrifugation, filtration, concentration, freeze-drying, and stored in a refrigerated room And the primary extract may be prepared into a powder state by an additional process such as vacuum distillation and freeze-drying or spray-drying. In addition, the primary extract can be further fractionated using a variety of chromatographies, such as silica gel column chromatography, thin layer chromatography, high performance liquid chromatography, .
따라서 본 발명에 있어서 상기 알로에베라잎, 아세로라, 녹차 또는 브로콜리 추출물은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Therefore, in the present invention, the aloe vera leaf, acerola, green tea or broccoli extract is a concept including all the extracts, fractions and tablets obtained in each step of extraction, fractionation or purification, their diluted solutions, concentrates or dried products.
본 발명에 따른 상기 피부 미백용 화장료 조성물은 화장료 조성물 총 100 중량부를 기준으로 알부틴 4.0 내지 6.0 중량부, 나이아신아마이드 1.0 내지 3.0 중량부, 알로에베라잎 추출물 0.05 내지 0.15 중량부, 아세로라 추출물 0.05 내지 0.15 중량부, 녹차잎 추출물 0.05 내지 0.15 중량부 및 브로콜리 추출물 0.05 내지 0.15 중량부를 포함하는 것일 수 있다.The cosmetic composition for skin whitening according to the present invention comprises 4.0 to 6.0 parts by weight of arbutin, 1.0 to 3.0 parts by weight of niacinamide, 0.05 to 0.15 part by weight of aloe vera leaf extract, 0.05 to 0.15 part by weight of acerola extract, 0.05 to 0.15 part by weight of green tea leaf extract and 0.05 to 0.15 part by weight of broccoli extract.
또한, 본 발명에 따른 상기 피부 미백용 화장료 조성물은 호호바씨 오일(Simmondsia chinensis seed oil) 및 아미노산 복합체(amino acid complex)를 추가로 포함하는 것일 수 있다.In addition, the cosmetic composition for skin whitening according to the present invention may further comprise a combination of jojoba seed oil (Simmondsia chinensis seed oil) and an amino acid complex.
본 발명의 상기 호호바씨 오일(Simmondsia chinensis (jojoba) seed oil)은 호호바 종자로부터 냉각압착법으로 얻어지는 오일로서, 화학구조가 피부 피지와 유사하여 피부에 잘 침투하기 때문에 끈적임이 적고 도톰하게 발리면서 목공을 막지않고 피지를 조절하여 피부조직세포 재생 효과가 탁월함은 물론, 보습 효과가 좋고, 피부에 자극이 없으면서도 항산화 효과와 함께 항염증 기능까지 갖추고 있어 민감성 피부에 효과가 좋은 것으로 알려져 있다.The Jojoba seed oil (Simmondsia chinensis (jojoba) seed oil) of the present invention is an oil obtained by joining the seeds of jojoba by cold pressing, and its chemical structure is similar to skin sebum and penetrates well to the skin. It is known that it is effective for sensitive skin because it has excellent anti-skin effect on skin tissue regeneration by regulating sebum without blocking, anti-inflammatory function with good moisturizing effect and antioxidant effect without skin irritation.
본 발명의 상기 아미노산 복합체(amino acid complex)는 피부 각질층 내의 아미노산 조성과 동일 또는 유사하게 구성된 아미노산의 복합물로서, 상기 아미노산 복합체는 피부세포에 영양을 공급하고 피부 섬유아세포를 활성화시켜 보습력 유지에 중요한 역할을 하는 것으로 알려져있다.The amino acid complex of the present invention is a complex of an amino acid that is the same as or similar to the amino acid composition in the stratum corneum of the skin. The amino acid complex plays an important role in maintaining moisturization by supplying nutrition to skin cells and activating skin fibroblasts .
본 발명에 따른 상기 아미노산 복합체는 라이신(lysine), 히스티딘(histidine), 아르기닌(arginine), 아스파르트산(aspartic acid), 트레오닌(threonine), 세린(serine), 글루탐산(gluamic acid), 프롤린(proline), 글리신(glycine), 알라닌(alanine), 발린(valine), 메치오닌(methionine), 이소류신(isoleucine), 류신(leucine), 티로신(tyrosine), 페닐알라닌(phenylalanine) 및 시스테인(cysteine)으로 이루어진 군으로부터 선택되는 2개 이상의 아미노산으로 구성된 것일 수 있다. 바람직하게는, 상기 17종의 아미노산을 동일한 중량으로 혼합하여 아미노산 복합체를 제조하는 것일 수 있다.The amino acid complexes according to the present invention may be used in combination with lysine, histidine, arginine, aspartic acid, threonine, serine, gluamic acid, proline, Selected from the group consisting of glycine, alanine, valine, methionine, isoleucine, leucine, tyrosine, phenylalanine and cysteine. Or more than two amino acids. Preferably, the above-mentioned 17 kinds of amino acids may be mixed by the same weight to prepare an amino acid complex.
본 발명에 따른 상기 피부 미백용 화장료 조성물은 화장료 조성물 총 100 중량부를 기준으로 호호바씨 오일 0.5 내지 1.5 중량부 및 아미노산 복합체 0.07 내지 0.27 중량부를 포함하는 것일 수 있다.The cosmetic composition for skin whitening according to the present invention may comprise 0.5 to 1.5 parts by weight of jojoba seed oil and 0.07 to 0.27 parts by weight of amino acid complex based on 100 parts by weight of the total cosmetic composition.
본 발명에 따른 상기 아미노산 복합체는 상기 피부 미백용 화장료 조성물 총 100 중량부를 기준으로 라이신 0.005 내지 0.015 중량부, 히스티딘 0.005 내지 0.015 중량부, 아르기닌 0.005 내지 0.015 중량부, 아스파르트산 0.005 내지 0.015 중량부, 트레오닌 0.005 내지 0.015 중량부, 세린 0.005 내지 0.015 중량부, 글루탐산 0.005 내지 0.015 중량부, 프롤린 0.005 내지 0.015 중량부, 글리신 0.005 내지 0.015 중량부, 알라닌 0.005 내지 0.015 중량부, 발린 0.005 내지 0.015 중량부, 메치오닌 0.005 내지 0.015 중량부, 이소류신 0.005 내지 0.015 중량부, 류신 0.005 내지 0.015 중량부, 티로신 0.005 내지 0.015 중량부, 페닐알라닌 0.005 내지 0.015 중량부 및 시스테인 0.005 내지 0.015 중량부를 포함하는 것일 수 있다.The amino acid conjugate according to the present invention may contain 0.005 to 0.015 part by weight of lysine, 0.005 to 0.015 part by weight of histidine, 0.005 to 0.015 part by weight of arginine, 0.005 to 0.015 part by weight of aspartic acid, 0.005 to 0.015 part by weight of glutamic acid, 0.005 to 0.015 part by weight of glutamic acid, 0.005 to 0.015 part by weight of proline, 0.005 to 0.015 part by weight of glycine, 0.005 to 0.015 part by weight of alanine, 0.005 to 0.015 part by weight of valine, 0.005 to 0.015 part by weight of isoleucine, 0.005 to 0.015 part by weight of leucine, 0.005 to 0.015 part by weight of tyrosine, 0.005 to 0.015 part by weight of phenylalanine and 0.005 to 0.015 part by weight of cysteine.
본 발명에서는 알부틴, 나이아신아마이드, 알로에베라잎 추출물, 아세로라 추출물, 녹차 추출물 및 브로콜리 추출물과 함께 호호바씨 오일 및 아미노산 복합체를 혼합한 화장료 조성물을 사용할 경우 미백 효과가 매우 우수한 것을 확인하였으며, 특히 알부틴 및 나이아신아마이드만을 함유할 경우 나타나는 피부 자극을 현저하게 감소시키는 피부 진정 효과를 가짐을 실험적으로 입증하였고(실험예 1 및 실험예 2 참조), 각 성분의 함량에 따른 피부 진정 효과를 비교하여 최적 함량 범위를 확인하였다(실험예 3 참조).In the present invention, it was confirmed that the cosmetic composition comprising a combination of arbutin, niacinamide, aloe vera leaf extract, acerola extract, green tea extract and broccoli extract together with jojoba seed oil and amino acid complex was excellent in whitening effect, and arbutin and niacin (Experimental Example 1 and Experimental Example 2), and the skin soothing effect according to the content of each ingredient was compared to determine the optimal content range (See Experimental Example 3).
본 발명에 따른 상기 피부 미백용 화장료 조성물은 상기 화장료 조성물 총 100 중량부를 기준으로 알부틴 4.0 내지 6.0 중량부, 나이아신아마이드 1.0 내지 3.0 중량부, 알로에베라잎 추출물 0.08 내지 0.12 중량부, 아세로라 추출물 0.08 내지 0.12 중량부, 녹차잎 추출물 0.08 내지 0.12 중량부, 브로콜리 추출물 0.08 내지 0.12 중량부, 호호바씨 오일 0.8 내지 1.2 중량부 및 아미노산 복합체 0.12 내지 0.22 중량부를 포함하는 것일 수 있다.The cosmetic composition for skin whitening according to the present invention comprises 4.0 to 6.0 parts by weight of arbutin, 1.0 to 3.0 parts by weight of niacinamide, 0.08 to 0.12 parts by weight of aloe vera leaf extract, 0.08 to 0.12 parts by weight of acerola extract, 0.08 to 0.12 parts by weight of green tea leaf extract, 0.08 to 0.12 parts by weight of broccoli extract, 0.8 to 1.2 parts by weight of jojoba seed oil and 0.12 to 0.22 parts by weight of amino acid complex.
본 발명에 따른 상기 피부 미백용 화장료 조성물은 크림, 영양크림, 모이스쳐크림, 핸드크림, 맛사지크림, 영양로션, 모이스쳐로션, 밀크로션, 로션, 아스트린젠트, 스킨로션, 스킨소프너, 스킨토너, 에센스, 영양에센스, 파운데이션, 메이크업 베이스, 팩, 패치, 겔, 파우더, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 또는 바디클린저로 구성된 군으로부터 선택되는 1종 이상의 제형인 것일 수 있다.The cosmetic composition for skin whitening according to the present invention can be used as a skin whitening cosmetic composition according to the present invention as a cream whitening cream for skin whitening, It may be one or more formulations selected from the group consisting of essence, foundation, makeup base, pack, patch, gel, powder, soap, cleansing foam, cleansing lotion, cleansing cream, body lotion or body cleanser.
본 발명의 화장료 조성물에는 각 제형의 외용제 조성물에 있어서, 상기한 필수 성분 이외의 다른 성분들은 기타 외용제의 제형 또는 사용 목적 등에 따라 당업자가 어려움 없이 적의 선정하여 배합할 수 있다.In the cosmetic composition of the present invention, components other than the above-mentioned essential components in the external preparation for each formulation can be appropriately selected and mixed by those skilled in the art according to the formulation or purpose of use of the external preparation.
또한, 본 발명의 화장료 조성물은 상기 유효성분 외에 피부보습제, 피부유연화제, 수분차단제 등 피부에 도움을 줄 수 있는 피부보호제를 추가로 더 포함할 수 있으며, 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 유연제, 항산화제, 현탁화제, 안정화제, pH 조정제, 발포제, 방향제, 계면활성제, 물, 유화제, 점증제, 충전제, 금속이온 봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 향료, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 이들 보조제는 화장품학 분야에서 일반적으로 사용되는 양으로 도입된다.In addition, the cosmetic composition of the present invention may further comprise a skin protecting agent which can provide skin care, such as a skin moisturizing agent, a skin softening agent, a moisture blocking agent, A preservative, a vitamin, a blocking agent, an antioxidant, an antioxidant, a preservative, a preservative, an antioxidant, an antioxidant, a preservative, a stabilizer, a pH adjuster, a foaming agent, Such as wetting agents, essential oils, fragrances, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or any other ingredients commonly used in cosmetics. These adjuvants are introduced in amounts commonly used in the cosmetics field.
상기 피부보호제로서는 부용추출물, 인도유향수지추출물, 스쿠알란, 하이드롤라이즈드콜라겐, 알란토인, 카프릴하이드록사믹애씨드, 하이알루로닉애씨드, 로즈마리추출물, 고삼추출물, 토코페릴아세테이트, D-판테놀 등을 이용할 수 있다. Examples of the skin protection agent include extracts derived from bark extract, Indian oriental resin extract, squalane, hydrolyzed collagen, allantoin, caprylic hydroxamic acid, hyaluronic acid, rosemary extract, gossam extract, tocopheryl acetate, D- Can be used.
상기 습윤화제로서는 글리세린, 부틸렌글리콜, 소듐하이알루로네이트, 세린, 솔비톨, 만니톨, 프로필렌글리콜, 에틸렌글리콜, 콜레스테롤, 콜레스테롤에스테르 등을 이용할 수 있다.As the wetting agent, glycerin, butylene glycol, sodium hyaluronate, serine, sorbitol, mannitol, propylene glycol, ethylene glycol, cholesterol, cholesterol ester and the like can be used.
유화제로서는 글리세릴스테아레이트, 피이지-40스테아레이트, 소르비탄세스퀴올레이트, 폴리소르베이트60, 글릴세스테아레이트/피이지-100스테아레이트, 친유형 글리세릴스테아레이트 등을 이용할 수 있다.As the emulsifier, glyceryl stearate, phage-40 stearate, sorbitan sesquioleate, polysorbate 60, glycystearate / phage-100 stearate, pro-type glyceryl stearate and the like can be used.
유연제로서는 카프릴릭/카프릭트리글리세라이드, 세테아릴알코올, 사이클로펜타실록산, 세틸에칠헥사노에이트, 사이클로헥사실록산, 카프릴릴글라이콜, 트리옥타노인, 세틸옥타노에이트, 스테아릭애씨드, 사이클로메치콘, 쉐어버터, 라놀린, 다메치콘 등을 이용할 수 있다.Examples of softening agents include caprylic / capric triglyceride, cetearyl alcohol, cyclopentasiloxane, cetylhexylhexanoate, cyclohexasiloxane, caprylylglycol, trioctanoin, cetyl octanoate, stearic acid, Cyclomethicone, shea butter, lanolin, dimethicone, and the like.
pH 조정제로서는 트리에탄올아민, 시트르산, 시트르산나트륨, 말산, 말산나트륨, 프말산, 프말산나트륨, 숙신산, 숙신산나트륨, 수산화나트륨, 인산일수소나트륨 등을 이용할 수 있다.As the pH adjusting agent, triethanolamine, citric acid, sodium citrate, malic acid, sodium malate, fumaric acid, sodium fumarate, succinic acid, sodium succinate, sodium hydroxide, sodium monohydrogen phosphate and the like can be used.
점증제로서는 카보머, 하이드록시에칠아크릴레이트/소듐아크릴로일디메칠티우레이트코폴리머 등을 이용할 수 있고, 킬레이트화제로서는 디소듐이디티에이를 이용할 수 있으며, 용제로서는 정제수, 1,2-헥산디올 등을 이용할 수 있다.Examples of the thickener include carbomer, hydroxyethyl methacrylate / sodium acryloyldimethyl thioureate copolymer, etc. As the chelating agent, disodium edetate may be used. Examples of the solvent include purified water, 1,2-hexane Diol, and the like.
이하, 본 발명을 실시예에 의하여 더욱 상세하게 설명한다. 이들 실시예는 단지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 국한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail by way of examples. It will be apparent to those skilled in the art that these embodiments are merely illustrative of the present invention and that the scope of the present invention is not limited to these embodiments.
<< 실시예Example 1> 알부틴, 1> Arbutin, 나이아신아마이드Niacinamide 및 식물 추출물 함유 And plant extract 화장료Cosmetics 조성물 제조 Composition manufacturing
완전히 건조된 알로에베라잎 100g을 분쇄한 뒤, 70% 에탄올(EtOH) 수용액 1L를 사용하여, 용매추출법을 이용하여 추출하였다. 추출 시 효율을 높이기 위해 교반기를 이용하여 48시간동안 교반하며 추출물을 제조하였다. 이를 50℃ 이하에서 감압 농축 후 동결건조하여 분말상의 알로에베라잎 추출물을 수득하였다.100 g of completely dried aloe vera leaves were pulverized and then extracted with 1 L of 70% ethanol (EtOH) aqueous solution using a solvent extraction method. The extracts were prepared by stirring for 48 hours using an agitator to increase the extraction efficiency. This was concentrated under reduced pressure at 50 DEG C or below and then lyophilized to obtain a powdery aloe vera leaf extract.
상기와 동일한 방법을 사용하여 아세로라 추출물, 녹차잎 추출물 및 브로콜리 추출물을 수득하였다.Using the same method as above, acerola extract, green tea leaf extract and broccoli extract were obtained.
수득된 추출물과 알부틴 및 나이아신아마이드를 하기 표 1의 조성으로 화장료 조성물(실시예 1)을 제조하였다.Cosmetic composition (Example 1) was prepared with the obtained extract, arbutin and niacinamide in the composition shown in Table 1 below.
<< 실시예Example 2> 알부틴, 2> arbutin, 나이아신아마이드Niacinamide , 식물 추출물, , Plant extracts, 호호바씨Mr. Jooba 오일 및 아미노산 복합체 함유 화장료 조성물 제조 Preparation of cosmetic composition containing oil and amino acid complex
라이신, 히스티딘, 아르기닌, 아스파르트산, 트레오닌, 세린, 글루탐산, 프롤린 글리신, 알라닌, 발린, 메치오닌, 이소류신, 류신, 티로신, 페닐알라닌 및 시스테인을 동일한 중량으로 혼합하여 아미노산 복합체를 제조하였다.Amino acid complexes were prepared by mixing equal amounts of lysine, histidine, arginine, aspartic acid, threonine, serine, glutamic acid, proline glycine, alanine, valine, methionine, isoleucine, leucine, tyrosine, phenylalanine and cysteine.
상기 아미노산 복합체와 호호바씨 오일, 상기 실시예 1에서 수득된 추출물, 알부틴 및 나이아신아마이드를 하기 표 2의 조성으로 화장료 조성물(실시예 2)을 제조하였다.The cosmetic composition (Example 2) was prepared from the amino acid complex and the jojoba seed oil, the extract obtained in Example 1, arbutin and niacinamide in the composition shown in Table 2 below.
<< 비교예Comparative Example 1> 알부틴 및 1> Arbutin and 나이아신Niacin 아마이드Amide 함유 contain 화장료Cosmetics 조성물 제조 Composition manufacturing
상기 실시예 1 또는 실시예 2의 식물 추출물, 알부틴, 나이아신아마이드, 호호바씨 오일 및 아미노산 복합체를 하기 표 3의 조성으로 화장료 조성물(비교예 1 내지 3)을 제조하였다.The cosmetic compositions (Comparative Examples 1 to 3) were prepared from the plant extracts, arbutin, niacinamide, jojoba seed oil and amino acid complexes of Example 1 or Example 2 in the composition shown in Table 3 below.
<< 실험예Experimental Example 1> 1> 화장료Cosmetics 조성물의 미백 효과 및 피부 자극 유무 분석 Whitening effect of composition and analysis of skin irritation
상기 실시예 1 및 실시예 2와 비교예 1 내지 3의 화장료 조성물의 미백 효과를 확인하기 위하여, 무작위로 선발된 건강한 피부를 가진 19~22세의 여성을 대상으로 인공색소 침착을 유도한 뒤 6주간 상기 화장료 조성물을 사용하게 한 후 피부 미백 효과 및 피부 자극 유무를 평가하였다.To confirm the whitening effect of the cosmetic compositions of Examples 1 and 2 and Comparative Examples 1 to 3, artificial pigmentation was induced in women 19 to 22 years old with healthy skin selected randomly, After using the above-mentioned cosmetic composition for weeks, skin whitening effect and skin irritation were evaluated.
구체적으로, 화장료 조성물 사용 전과 사용 1주, 2주, 4주 및 6주 후 시점에서 피부 미백 효과를 평가하였다. 평가 기준은 1~7점 척도를 사용하였고, '색소 침착 없음'은 0점, '없거나 가벼운 색소침착'은 1점, '가벼운 색소침착'은 2점, '가볍거나 보통의 색소침착'은 3점, '보통의 색소침착'은 4점, '보통이거나 심한 색소침착'은 5점, '심한 색소침착'은 6점, '매우 심한 색소침착'은 7점으로 표기하도록 하였다. 각 화장료 조성물의 미백 효과를 각 시점별로 2명의 관찰자가 평가하였고, 실험결과는 하기 표 4 및 표 5에 평가 대상자 10명의 평균점수로 표기하였다. 표 4는 관찰자 1에 의한 육안 평가 결과이고, 표 5는 관찰자 2에 의한 육안 평가 결과이다. 피부자극의 유무는 (자극을 보인 명수)/(총 시험자수)로 평가하였다.Specifically, skin whitening effect was evaluated before use of the cosmetic composition and at 1, 2, 4, and 6 weeks after use. The criteria for evaluation were 1 to 7 points, 0 for no pigmentation, 1 for no or light pigmentation, 2 for light pigmentation, 3 for light or moderate pigmentation 4 points for 'normal pigmentation', 5 points for 'normal or severe pigmentation', 6 points for 'severe pigmentation', and 7 points for 'very severe pigmentation'. Two observers evaluated the whitening effect of each cosmetic composition at each time point, and the experimental results are shown in the following Tables 4 and 5 as the average scores of the subjects to be evaluated. Table 4 shows the results of visual evaluation by observer 1, and Table 5 shows results of visual evaluation by observer 2. The presence or absence of skin irritation was evaluated by (number of stimuli) / (total number of test subjects).
그 결과, 실시예 1 및 실시예 2의 화장료 조성물이 비교예 1 내지 비교예 3의 화장료 조성물보다 미백효과가 더 우수한 것으로 나타났고, 특히 실시예 2를 사용한 경우 가장 우수한 미백 효과가 나타남을 확인하였다.As a result, the cosmetic compositions of Examples 1 and 2 showed a better whitening effect than the cosmetic compositions of Comparative Examples 1 to 3, and it was confirmed that the whitening effect was the most excellent when Example 2 was used .
비교예 1 내지 3을 사용한 경우에도 미백 효과를 보이고 있으나, 알부틴 및 나이아신아마이드만을 함유한 화장료(비교예 1)를 사용한 경우 피부 자극이 많이 유발된 것으로 나타났고, 비교예 2 및 3 역시 사용함에 있어 실시예 1 및 2에 비해 자극이 강하여 장기적으로 사용하기에 피부 자극의 우려가 있었다. 그러나 본원 발명에 따른 화장료 조성물(실시예 1 및 2)은 피부 자극이 거의 나타나지 않았다. 이러한 결과로부터 상기 실시예 1 또는 2의 화장료 조성물은 미백 효과를 나타낼 뿐만 아니라 알부틴 및 나이아신아마이드에 의해 유발되는 피부자극을 완화시킬 수 있음을 확인하였다.Even when Comparative Examples 1 to 3 were used, whitening effect was shown. However, when cosmetic compositions containing only arbutin and niacinamide (Comparative Example 1) were used, skin irritation was largely induced, and Comparative Examples 2 and 3 were also used Compared with Examples 1 and 2, stimulation was strong and there was a fear of skin irritation for long-term use. However, the cosmetic composition according to the present invention (Examples 1 and 2) showed little skin irritation. From these results, it was confirmed that the cosmetic composition of Example 1 or 2 not only showed a whitening effect but also relieved skin irritation caused by arbutin and niacinamide.
<< 실험예Experimental Example 2> 2> 화장료Cosmetics 조성물의 피부 진정 효과 분석 Analysis of skin soothing effect of composition
현재 피부 알레르기 증상이 없는 20 내지 30대 남녀 10명을 대상으로 하완의 안쪽 부위에 테입 스트리핑 법(Tape Stripping Method)을 통한 피부자극을 유발한 후, 본 발명에 따른 복합발효추출물을 함유한 화장료와 함유되지 않는 화장료를 도포하여 유발된 자극이 진정되는 정도를 상대평가하였다. 먼저, 하완의 안쪽 부위 두 곳에 일반 스카치 테잎으로 30회 테이핑을 하여 피부 홍반을 유발하였다. 홍반이 유발된 후, 상시 실시예 1, 실시예 2 및 비교예 1 내지 3의 화장료 조성물을 도포하여, 도포 후 3시간 후 피부진정 정도를 평가하였다.The present invention relates to a cosmetic composition containing a complex fermented extract according to the present invention and a cosmetic composition containing the complex fermented extract according to the present invention, The degree to which stimulation induced by applying a cosmetic composition not contained was calibrated relative to each other. First, taping was repeated 30 times with a scotch tape on both sides of the underbody to cause skin erythema. After erythema was induced, the cosmetic compositions of Example 1, Example 2 and Comparative Examples 1 to 3 were applied at all times and the degree of skin soothing was evaluated 3 hours after application.
평가 기준은 1~5점 척도를 사용하였고, '무반응'은 0점, '매우 경미한 홍반흔적'은 1점, '희미한 또는 가벼운 홍반'은 2점, '경계가 뚜렷하나 약한 홍반'은 3점, '뚜렷한 홍반'은 4점, '심한 홍반'은 5점으로 표기하도록 하였다. 실험결과는 하기 표 6에 평가 대상자 10명의 평균점수로 표기하였다.The criteria for evaluation were 1 to 5, 0 for no response, 1 for very mild erythema, 2 for faint or mild erythema, and 1 for weak erythema 4 points for 'marked erythema', and 5 points for 'severe erythema'. The experimental results are shown in Table 6 as the average score of 10 subjects.
상기 표 6에서 확인되는 바와 같이 본 발명에 따른 실시예 2의 알부틴, 나이아신아마이드, 알로에베라잎 추출물, 아세로라 추출물, 녹차잎 추출물, 브로콜리 추출물, 호호바씨 오일 및 아미노산 복합체를 모두 함유하는 화장료 조성물을 사용한 경우, 실시예 1 또는 비교예에 비해 피부 진정 효과가 뛰어난 것을 확인할 수 있었다.As shown in Table 6, cosmetic composition containing all of arbutin, niacinamide, aloe vera leaf extract, acerola extract, green tea leaf extract, broccoli extract, jojoba seed oil and amino acid complex according to Example 2 of the present invention , It was confirmed that the skin soothing effect was superior to that of Example 1 or Comparative Example.
<< 실험예Experimental Example 3> 3> 화장료Cosmetics 조성물에서 각 성분의 함량에 따른 피부 진정 효과 분석 Analysis of skin soothing effect according to the content of each ingredient in the composition
피부 미백 및 피부 진정 효과가 가장 우수한 실시예 2의 화장료 조성물에 대하여, 각 성분의 함량에 따른 피부 진정 효과를 확인하기 위해 알로에베라잎 추출물, 아세로라 추출물, 녹차잎 추출물, 브로콜리 추출물, 호호바씨 오일 및 아미노산 복합체의 함량을 달리하여 하기 표 7 내지 표 12의 조성으로 실시예 3 내지 실시예 26의 화장료 조성물을 제조하였고, 실험예 2와 동일한 방법으로 각 화장료 조성물의 피부 진정 효과를 평가하였다. 이때, 상기 성분 외의 다른 성분들의 함량은 실시예 2와 동일하게 혼합하였다.In order to confirm the skin soothing effect according to the content of each ingredient, the cosmetic composition of Example 2, which has the best skin whitening and skin soothing effect, is selected from aloe vera leaf extract, acerola extract, green tea leaf extract, broccoli extract, Amino acid complexes were prepared in the same manner as in Experimental Example 2, and the skin soothing effects of the respective cosmetic compositions were evaluated in the same manner as in Experimental Example 2. At this time, the contents of the components other than the above components were mixed in the same manner as in Example 2.
중량%)(unit:
weight%)
Arbutin
Niacinamide
Acerola extract
Green tea extract
Broccoli extract
Jojoba seed oil
Amino acid complex
(홍반) 정도Skin irritation
(Erythema) degree
중량%)(unit:
weight%)
Arbutin
Niacinamide
Acerola extract
Green tea extract
Broccoli extract
Jojoba seed oil
Amino acid complex
(홍반) 정도Skin irritation
(Erythema) degree
중량%)(unit:
weight%)
Arbutin
Niacinamide
Acerola extract
Green tea extract
Broccoli extract
Jojoba seed oil
Amino acid complex
(홍반) 정도Skin irritation
(Erythema) degree
중량%)(unit:
weight%)
Arbutin
Niacinamide
Acerola extract
Green tea extract
Broccoli extract
Jojoba seed oil
Amino acid complex
(홍반) 정도Skin irritation
(Erythema) degree
중량%)(unit:
weight%)
Arbutin
Niacinamide
Acerola extract
Green tea extract
Broccoli extract
Jojoba seed oil
Amino acid complex
(홍반) 정도Skin irritation
(Erythema) degree
중량%)(unit:
weight%)
Arbutin
Niacinamide
Acerola extract
Green tea extract
Broccoli extract
Jojoba seed oil
Amino acid complex
(홍반) 정도Skin irritation
(Erythema) degree
그 결과, 화장료 조성물 총 중량에 대하여, 알로에베라잎 추출물 0.08 내지 0.12 중량%, 아세로라 추출물 0.08 내지 0.12 중량%, 녹차 추출물 0.08 내지 0.12 중량%, 브로콜리 추출물 0.08 내지 0.12 중량%, 호호바씨 오일 0.80 내지 1.20 중량% 및 아미노산 복합체 0.12 내지 0.22 중량% 범위의 함량으로 포함하는 화장료 조성물에서 피부 진정 효과가 나타났고, 특히, 알로에베라잎 추출물 0.10 중량%, 아세로라 추출물 0.10 중량%, 녹차 추출물 0.10 중량%, 브로콜리 추출물 0.10 중량%, 호호바씨 오일 1.00 중량% 및 아미노산 복합체 0.17 중량%를 포함하는 화장료 조성물의 피부 진정 효과가 가장 우수한 것을 확인하였다.As a result, 0.08 to 0.12 wt% of aloe vera leaf extract, 0.08 to 0.12 wt% of acerola extract, 0.08 to 0.12 wt% of green tea extract, 0.08 to 0.12 wt% of broccoli extract, 0.80 to 1.20 wt% of broccoli extract, The present invention relates to a cosmetic composition comprising 0.1% by weight of aloe vera leaf extract, 0.10% by weight of acerola extract, 0.10% by weight of green tea extract, 0.1% by weight of broccoli extract, 0.10 wt.%, Jojoba seed oil 1.00 wt.% And amino acid complex 0.17 wt.%.
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.The present invention has been described with reference to the preferred embodiments. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Therefore, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the present invention is defined by the appended claims rather than by the foregoing description, and all differences within the scope of equivalents thereof should be construed as being included in the present invention.
Claims (8)
상기 피부 미백용 화장료 조성물은 호호바씨 오일(Simmondsia chinensis seed oil) 및 아미노산 복합체(amino acid complex)를 추가로 포함하는 것인 피부 미백용 화장료 조성물.The method according to claim 1,
Wherein the cosmetic composition for skin whitening further comprises a combination of jojoba seed oil (Simmondsia chinensis seed oil) and an amino acid complex.
상기 피부 미백용 화장료 조성물 총 100 중량부를 기준으로 알부틴 4.0 내지 6.0 중량부, 나이아신아마이드 1.0 내지 3.0 중량부, 알로에베라잎 추출물 0.05 내지 0.15 중량부, 아세로라 추출물 0.05 내지 0.15 중량부, 녹차잎 추출물 0.05 내지 0.15 중량부 및 브로콜리 추출물 0.05 내지 0.15 중량부를 포함하는 것인 피부 미백용 화장료 조성물.The method according to claim 1,
4.0 to 6.0 parts by weight of arbutin, 1.0 to 3.0 parts by weight of niacinamide, 0.05 to 0.15 part by weight of aloe vera leaf extract, 0.05 to 0.15 part by weight of acerola extract, 0.05 to 0.15 part by weight of green tea leaf extract, 0.15 parts by weight of the extract and 0.05 to 0.15 parts by weight of the broccoli extract.
상기 피부 미백용 화장료 조성물 총 100 중량부를 기준으로 호호바씨 오일 0.5 내지 1.5 중량부 및 아미노산 복합체 0.07 내지 0.27 중량부를 포함하는 것인 피부 미백용 화장료 조성물.3. The method of claim 2,
0.5 to 1.5 parts by weight of jojoba seed oil and 0.07 to 0.27 part by weight of amino acid complex based on 100 parts by weight of the total amount of the skin whitening cosmetic composition.
상기 피부 미백용 화장료 조성물 총 100 중량부를 기준으로 알부틴 4.0 내지 6.0 중량부, 나이아신아마이드 1.0 내지 3.0 중량부, 알로에베라잎 추출물 0.08 내지 0.12 중량부, 아세로라 추출물 0.08 내지 0.12 중량부, 녹차잎 추출물 0.08 내지 0.12 중량부, 브로콜리 추출물 0.08 내지 0.12 중량부, 호호바씨 오일 0.8 내지 1.2 중량부 및 아미노산 복합체 0.12 내지 0.22 중량부를 포함하는 것인 피부 미백용 화장료 조성물.5. The method according to any one of claims 1 to 4,
4.0 to 6.0 parts by weight of arbutin, 1.0 to 3.0 parts by weight of niacinamide, 0.08 to 0.12 part by weight of aloe vera leaf extract, 0.08 to 0.12 part by weight of acerola extract, 0.08 part by weight of green tea leaf extract, 0.12 parts by weight of a broccoli extract, 0.08 to 0.12 parts by weight of a broccoli extract, 0.8-1.2 parts by weight of a jojoba seed oil and 0.12-0.22 parts by weight of an amino acid complex.
상기 아미노산 복합체는 라이신(lysine), 히스티딘(histidine), 아르기닌(arginine), 아스파르트산(aspartic acid), 트레오닌(threonine), 세린(serine), 글루탐산(gluamic acid), 프롤린(proline), 글리신(glycine), 알라닌(alanine), 발린(valine), 메치오닌(methionine), 이소류신(isoleucine), 류신(leucine), 티로신(tyrosine), 페닐알라닌(phenylalanine) 및 시스테인(cysteine)으로 이루어진 군으로부터 선택되는 2개 이상의 아미노산으로 구성된 것인 피부 미백용 화장료 조성물.3. The method of claim 2,
The amino acid complex may be selected from the group consisting of lysine, histidine, arginine, aspartic acid, threonine, serine, gluamic acid, proline, glycine, (S) selected from the group consisting of alanine, valine, methionine, isoleucine, leucine, tyrosine, phenylalanine and cysteine. Wherein the cosmetic composition comprises an amino acid.
상기 피부 미백용 화장료 조성물 총 100 중량부를 기준으로 라이신 0.005 내지 0.015 중량부, 히스티딘 0.005 내지 0.015 중량부, 아르기닌 0.005 내지 0.015 중량부, 아스파르트산 0.005 내지 0.015 중량부, 트레오닌 0.005 내지 0.015 중량부, 세린 0.005 내지 0.015 중량부, 글루탐산 0.005 내지 0.015 중량부, 프롤린 0.005 내지 0.015 중량부, 글리신 0.005 내지 0.015 중량부, 알라닌 0.005 내지 0.015 중량부, 발린 0.005 내지 0.015 중량부, 메치오닌 0.005 내지 0.015 중량부, 이소류신 0.005 내지 0.015 중량부, 류신 0.005 내지 0.015 중량부, 티로신 0.005 내지 0.015 중량부, 페닐알라닌 0.005 내지 0.015 중량부 및 시스테인 0.005 내지 0.015 중량부를 포함하는 것인 피부 미백용 화장료 조성물.3. The method of claim 2,
0.005 to 0.015 parts by weight of lysine, 0.005 to 0.015 part by weight of histidine, 0.005 to 0.015 part by weight of arginine, 0.005 to 0.015 part by weight of aspartic acid, 0.005 to 0.015 part by weight of threonine, 0.005 to 0.015 part by weight of glutamic acid, 0.005 to 0.015 part by weight of proline, 0.005 to 0.015 part by weight of glycine, 0.005 to 0.015 part by weight of alanine, 0.005 to 0.015 part by weight of valine, 0.005 to 0.015 part by weight of methionine, 0.015 to 0.015 part by weight of leucine, 0.005 to 0.015 part by weight of leucine, 0.005 to 0.015 part by weight of tyrosine, 0.005 to 0.015 part by weight of phenylalanine and 0.005 to 0.015 part by weight of cysteine.
상기 피부 미백용 화장료 조성물은 크림, 영양크림, 모이스쳐크림, 핸드크림, 맛사지크림, 영양로션, 모이스쳐로션, 밀크로션, 로션, 아스트린젠트, 스킨로션, 스킨소프너, 스킨토너, 에센스, 영양에센스, 파운데이션, 메이크업 베이스, 팩, 패치, 겔, 파우더, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 또는 바디클린저로 구성된 군으로부터 선택되는 1종 이상의 제형인 것인 피부 미백용 화장료 조성물.The method according to claim 1,
The cosmetic composition for skin whitening may be at least one selected from the group consisting of cream, nutritional cream, moisturizing cream, hand cream, massage cream, nutritional lotion, Wherein the composition is at least one formulation selected from the group consisting of a makeup base, a pack, a patch, a gel, a powder, a soap, a cleansing foam, a cleansing lotion, a cleansing cream, a body lotion or a body cleanser.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170105916A KR102027647B1 (en) | 2017-08-22 | 2017-08-22 | Low irritating cosmetic composition for skin whitening comprising albutin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170105916A KR102027647B1 (en) | 2017-08-22 | 2017-08-22 | Low irritating cosmetic composition for skin whitening comprising albutin |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190020950A true KR20190020950A (en) | 2019-03-05 |
KR102027647B1 KR102027647B1 (en) | 2019-11-04 |
Family
ID=65760400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170105916A Active KR102027647B1 (en) | 2017-08-22 | 2017-08-22 | Low irritating cosmetic composition for skin whitening comprising albutin |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102027647B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210060009A (en) * | 2019-11-18 | 2021-05-26 | 한남대학교 산학협력단 | Wash-off pack Cosmetic composition for skin whitening and manufacturing method thereof |
KR20220017278A (en) * | 2020-08-04 | 2022-02-11 | 주식회사 이엔코스 | Low irritating cosmetic composition for skin whitening comprising albutin, Polygonum tinctorium leaf and Brassica napus whole plant |
CN115969756A (en) * | 2022-12-09 | 2023-04-18 | 广州善草纪化妆品有限公司 | Anti-allergic, whitening and freckle-removing composition and preparation method thereof |
CN118557498A (en) * | 2024-06-12 | 2024-08-30 | 至荣(广州)化妆品有限公司 | Freckle-removing and whitening composition and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100923141B1 (en) | 2007-12-26 | 2009-10-23 | 부산대학교 산학협력단 | Skin whitening composition comprising arbutin beta derivative |
KR20100069759A (en) | 2008-12-17 | 2010-06-25 | (주)화진사이언스 | Cosmetic compositions for removing dark spots and liver spots and thereof manufacturing method |
-
2017
- 2017-08-22 KR KR1020170105916A patent/KR102027647B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100923141B1 (en) | 2007-12-26 | 2009-10-23 | 부산대학교 산학협력단 | Skin whitening composition comprising arbutin beta derivative |
KR20100069759A (en) | 2008-12-17 | 2010-06-25 | (주)화진사이언스 | Cosmetic compositions for removing dark spots and liver spots and thereof manufacturing method |
Non-Patent Citations (1)
Title |
---|
블로그 제목 "[이엔코스] 알부틴5%크림으로 맑아지자", 공개일 2016.06.29.* * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210060009A (en) * | 2019-11-18 | 2021-05-26 | 한남대학교 산학협력단 | Wash-off pack Cosmetic composition for skin whitening and manufacturing method thereof |
KR20220017278A (en) * | 2020-08-04 | 2022-02-11 | 주식회사 이엔코스 | Low irritating cosmetic composition for skin whitening comprising albutin, Polygonum tinctorium leaf and Brassica napus whole plant |
CN115969756A (en) * | 2022-12-09 | 2023-04-18 | 广州善草纪化妆品有限公司 | Anti-allergic, whitening and freckle-removing composition and preparation method thereof |
CN118557498A (en) * | 2024-06-12 | 2024-08-30 | 至荣(广州)化妆品有限公司 | Freckle-removing and whitening composition and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR102027647B1 (en) | 2019-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101809266B1 (en) | Cosmetic composition containing propolis complex extracts | |
KR102015173B1 (en) | Low irritating cosmetic composition for skin whitening | |
KR101749690B1 (en) | Cosmetic composition for sebum control and pore minimizing containing Wrinkled Giant Hyssop. | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
KR102027647B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin | |
KR20240142281A (en) | Natural cosmetic composition using grains and herbal medicines | |
KR102130571B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin and extract of Euterpe oleracea fruit | |
KR101299024B1 (en) | Cosmetics composition for skin lightening color, antioxidantsand and method for preparing the same | |
KR101509848B1 (en) | Composition for skin external application comprising tanshinone ⅱa as the active ingredient | |
KR102255580B1 (en) | Cosmetic composition comprising Ilex paraguayensis extract and Tranexamic acid | |
KR102226179B1 (en) | Cosmetic Compositions for Anti-aging Comprising Extracts of Plants | |
KR102303644B1 (en) | Face cosmetics fermentation composition comprising vegetable mixed extract and tumeric extract | |
KR101458758B1 (en) | Garlic extract with the effect of skin whithening and anti-oxient, manufacturing method htereof and cosmetic composition comprising the same | |
KR20130022476A (en) | A cosmetic composition containing extract of artemisia iwayomogi | |
KR20210060801A (en) | Cosmetic Compositions for Anti-aging Comprising Complex Fermented Product of Plants | |
KR20160081176A (en) | Skin external composition for moisturing skin or whitening skin comprising catechins and panaxydol | |
KR20190137327A (en) | Skin external application composition for anti-aging | |
KR102365222B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin, Polygonum tinctorium leaf and Betula platyphylla japonica bark extract | |
KR102365223B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin, Polygonum tinctorium leaf and Brassica napus whole plant | |
KR101777368B1 (en) | Composition for skin-whitener containing extract of china rose | |
KR102644064B1 (en) | A cosmetic composition for skin wrinkle improvement containing mixed extracts of grape, olive leaf and myrrh as active ingredients | |
KR102431820B1 (en) | Cosmetic composition comprising extract of Citrus grandis Osbeck and Dendropanax morbifera | |
KR101894433B1 (en) | Composition for skin whitening comprising tofu sunmul | |
KR102566894B1 (en) | Cosmetic composition having anti-oxidant, anti-inflammatory and skin whiening effects which comprise DKMEX | |
JP7620395B2 (en) | Cosmetic composition and topical skin preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20170822 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190218 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
PN2301 | Change of applicant |
Patent event date: 20190415 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20190923 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20190925 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20190925 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20220627 Start annual number: 4 End annual number: 4 |